Additionally, changes in the treatment of T2DM practice over time, especially the introduction of SGLT2 inhibitors in 2012 by the European Medicines Agency, might be another reason for the increased incidence of UTIs in the diabetes mellitus cohort [24,25]. Here, SLC5A2 is linked to diabetes mellitus.